Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical ...
Researchers identified the enzyme CMPK2 as a possible target for therapies aiming to prevent metabolic dysfunction-associated ...
Citation: Flu antiviral baloxavir shows promise over other treatments for high-risk patients, shortening symptom duration (2025, January 16) retrieved 4 February 2025 from https://medicalxpress ...
BEIJING – The rapid spread of seasonal influenza in China in recent weeks has increased the demand for a certain antiviral medication, prompting health experts to warn against hoarding of pills ...
Antiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic review and meta ...